(JBL) Jabil Circuit - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4663131039
Stock: Electronic Hardware, Manufacturing, Design, Supply Chain, Assemblies
Total Rating 54
Risk 77
Buy Signal -0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 45.8% |
| Relative Tail Risk | -22.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.69 |
| Alpha | 60.98 |
| Character TTM | |
|---|---|
| Beta | 1.491 |
| Beta Downside | 1.334 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.83% |
| CAGR/Max DD | 1.30 |
EPS (Earnings per Share)
Revenue
Description: JBL Jabil Circuit March 05, 2026
Jabil Inc. provides engineering, manufacturing, and supply chain solutions globally. This business model, common in the Electronic Manufacturing Services (EMS) sector, involves producing components and finished goods for other companies.
The company operates across three segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. These segments encompass a wide range of services, including electronic hardware and embedded software design, mechanical design, and advanced optical solutions.
Jabil also offers specialized products like cloud data center server platforms, medical devices, and automotive assemblies. Their services extend to systems assembly, testing, and fulfillment, serving diverse industries such as 5G, healthcare, and automotive. Further research on ValueRay can provide more in-depth analysis of Jabils financial performance and market position.
Headlines to watch out for
- Global supply chain disruptions increase manufacturing costs
- Demand for 5G infrastructure drives revenue growth
- Healthcare device manufacturing expands regulated industries segment
- Automotive sector demand impacts electronics assembly volume
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 703.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.59 > 1.0 |
| NWC/Revenue: -0.53% < 20% (prev 2.89%; Δ -3.42% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.65b > Net Income 703.0m |
| Net Debt (1.80b) to EBITDA (1.99b): 0.90 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.3m) vs 12m ago -5.0% < -2% |
| Gross Margin: 8.94% > 18% (prev 0.09%; Δ 885.0% > 0.5%) |
| Asset Turnover: 168.0% > 50% (prev 154.7%; Δ 13.27% > 0%) |
| Interest Coverage Ratio: 4.58 > 6 (EBITDA TTM 1.99b / Interest Expense TTM 269.0m) |
Altman Z'' 1.87
| A: -0.01 (Total Current Assets 14.38b - Total Current Liabilities 14.55b) / Total Assets 19.28b |
| B: 0.34 (Retained Earnings 6.52b / Total Assets 19.28b) |
| C: 0.07 (EBIT TTM 1.23b / Avg Total Assets 18.52b) |
| D: 0.36 (Book Value of Equity 6.50b / Total Liabilities 17.93b) |
| Altman-Z'' Score: 1.87 = BBB |
Beneish M -2.83
| DSRI: 1.03 (Receivables 5.60b/4.82b, Revenue 31.11b/27.49b) |
| GMI: 1.02 (GM 8.94% / 9.12%) |
| AQI: 1.19 (AQ_t 0.08 / AQ_t-1 0.07) |
| SGI: 1.13 (Revenue 31.11b / 27.49b) |
| TATA: -0.05 (NI 703.0m - CFO 1.65b) / TA 19.28b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of JBL shares?
As of March 14, 2026, the stock is trading at USD 255.46 with a total of 1,000,101 shares traded.
Over the past week, the price has changed by +3.97%, over one month by -1.51%, over three months by +13.34% and over the past year by +92.35%.
Over the past week, the price has changed by +3.97%, over one month by -1.51%, over three months by +13.34% and over the past year by +92.35%.
Is JBL a buy, sell or hold?
Jabil Circuit has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy JBL.
- StrongBuy: 2
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JBL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 264.5 | 3.5% |
| Analysts Target Price | 264.5 | 3.5% |
JBL Fundamental Data Overview March 11, 2026
P/E Trailing = 38.7868
P/E Forward = 21.1416
P/S = 0.8496
P/B = 18.9419
P/EG = 0.8189
Revenue TTM = 31.11b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 1.99b USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 596.0m USD (from shortTermDebt, last quarter)
Debt = 3.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.80b USD (from netDebt column, last quarter)
Enterprise Value = 28.23b USD (26.43b + Debt 3.37b - CCE 1.57b)
Interest Coverage Ratio = 4.58 (Ebit TTM 1.23b / Interest Expense TTM 269.0m)
EV/FCF = 23.82x (Enterprise Value 28.23b / FCF TTM 1.19b)
FCF Yield = 4.20% (FCF TTM 1.19b / Enterprise Value 28.23b)
FCF Margin = 3.81% (FCF TTM 1.19b / Revenue TTM 31.11b)
Net Margin = 2.26% (Net Income TTM 703.0m / Revenue TTM 31.11b)
Gross Margin = 8.94% ((Revenue TTM 31.11b - Cost of Revenue TTM 28.33b) / Revenue TTM)
Gross Margin QoQ = 8.93% (prev 9.49%)
Tobins Q-Ratio = 1.46 (Enterprise Value 28.23b / Total Assets 19.28b)
Interest Expense / Debt = 1.87% (Interest Expense 63.0m / Debt 3.37b)
Taxrate = 33.64% (74.0m / 220.0m)
NOPAT = 816.9m (EBIT 1.23b * (1 - 33.64%))
Current Ratio = 0.99 (Total Current Assets 14.38b / Total Current Liabilities 14.55b)
Debt / Equity = 2.51 (Debt 3.37b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 0.90 (Net Debt 1.80b / EBITDA 1.99b)
Debt / FCF = 1.52 (Net Debt 1.80b / FCF TTM 1.19b)
Total Stockholder Equity = 1.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.80% (Net Income 703.0m / Total Assets 19.28b)
RoE = 51.13% (Net Income TTM 703.0m / Total Stockholder Equity 1.38b)
RoCE = 32.72% (EBIT 1.23b / Capital Employed (Equity 1.38b + L.T.Debt 2.39b))
RoIC = 19.18% (NOPAT 816.9m / Invested Capital 4.26b)
WACC = 10.26% (E(26.43b)/V(29.80b) * Re(11.41%) + D(3.37b)/V(29.80b) * Rd(1.87%) * (1-Tc(0.34)))
Discount Rate = 11.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -9.46%
[DCF] Terminal Value 74.28% ; FCFF base≈1.11b ; Y1≈1.36b ; Y5≈2.32b
[DCF] Fair Price = 237.1 (EV 26.83b - Net Debt 1.80b = Equity 25.03b / Shares 105.6m; r=10.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -20.75 | EPS CAGR: -44.34% | SUE: -4.0 | # QB: 0
Revenue Correlation: -40.43 | Revenue CAGR: 2.56% | SUE: 0.74 | # QB: 0
EPS next Quarter (2026-05-31): EPS=2.91 | Chg7d=+0.009 | Chg30d=+0.125 | Revisions Net=+7 | Analysts=7
EPS current Year (2026-08-31): EPS=11.60 | Chg7d=+0.012 | Chg30d=+0.483 | Revisions Net=+8 | Growth EPS=+19.0% | Growth Revenue=+8.9%
EPS next Year (2027-08-31): EPS=13.49 | Chg7d=+0.013 | Chg30d=+0.569 | Revisions Net=+8 | Growth EPS=+16.2% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.8% (Discount Rate 11.4% - Earnings Yield 2.6%)
[Growth] Growth Spread = -6.4% (Analyst 2.4% - Implied 8.8%)
P/E Forward = 21.1416
P/S = 0.8496
P/B = 18.9419
P/EG = 0.8189
Revenue TTM = 31.11b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 1.99b USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 596.0m USD (from shortTermDebt, last quarter)
Debt = 3.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.80b USD (from netDebt column, last quarter)
Enterprise Value = 28.23b USD (26.43b + Debt 3.37b - CCE 1.57b)
Interest Coverage Ratio = 4.58 (Ebit TTM 1.23b / Interest Expense TTM 269.0m)
EV/FCF = 23.82x (Enterprise Value 28.23b / FCF TTM 1.19b)
FCF Yield = 4.20% (FCF TTM 1.19b / Enterprise Value 28.23b)
FCF Margin = 3.81% (FCF TTM 1.19b / Revenue TTM 31.11b)
Net Margin = 2.26% (Net Income TTM 703.0m / Revenue TTM 31.11b)
Gross Margin = 8.94% ((Revenue TTM 31.11b - Cost of Revenue TTM 28.33b) / Revenue TTM)
Gross Margin QoQ = 8.93% (prev 9.49%)
Tobins Q-Ratio = 1.46 (Enterprise Value 28.23b / Total Assets 19.28b)
Interest Expense / Debt = 1.87% (Interest Expense 63.0m / Debt 3.37b)
Taxrate = 33.64% (74.0m / 220.0m)
NOPAT = 816.9m (EBIT 1.23b * (1 - 33.64%))
Current Ratio = 0.99 (Total Current Assets 14.38b / Total Current Liabilities 14.55b)
Debt / Equity = 2.51 (Debt 3.37b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 0.90 (Net Debt 1.80b / EBITDA 1.99b)
Debt / FCF = 1.52 (Net Debt 1.80b / FCF TTM 1.19b)
Total Stockholder Equity = 1.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.80% (Net Income 703.0m / Total Assets 19.28b)
RoE = 51.13% (Net Income TTM 703.0m / Total Stockholder Equity 1.38b)
RoCE = 32.72% (EBIT 1.23b / Capital Employed (Equity 1.38b + L.T.Debt 2.39b))
RoIC = 19.18% (NOPAT 816.9m / Invested Capital 4.26b)
WACC = 10.26% (E(26.43b)/V(29.80b) * Re(11.41%) + D(3.37b)/V(29.80b) * Rd(1.87%) * (1-Tc(0.34)))
Discount Rate = 11.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -9.46%
[DCF] Terminal Value 74.28% ; FCFF base≈1.11b ; Y1≈1.36b ; Y5≈2.32b
[DCF] Fair Price = 237.1 (EV 26.83b - Net Debt 1.80b = Equity 25.03b / Shares 105.6m; r=10.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -20.75 | EPS CAGR: -44.34% | SUE: -4.0 | # QB: 0
Revenue Correlation: -40.43 | Revenue CAGR: 2.56% | SUE: 0.74 | # QB: 0
EPS next Quarter (2026-05-31): EPS=2.91 | Chg7d=+0.009 | Chg30d=+0.125 | Revisions Net=+7 | Analysts=7
EPS current Year (2026-08-31): EPS=11.60 | Chg7d=+0.012 | Chg30d=+0.483 | Revisions Net=+8 | Growth EPS=+19.0% | Growth Revenue=+8.9%
EPS next Year (2027-08-31): EPS=13.49 | Chg7d=+0.013 | Chg30d=+0.569 | Revisions Net=+8 | Growth EPS=+16.2% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.8% (Discount Rate 11.4% - Earnings Yield 2.6%)
[Growth] Growth Spread = -6.4% (Analyst 2.4% - Implied 8.8%)